People · Operator
Named in public records as an officer, director or promoter · active 2021–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| MapLight Therapeutics, Inc. | — | Biotechnology | Series D+ | $356.2M | $1.5B | 2021 |
Anatol A Kreitzer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Anatol A Kreitzer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Christopher A. Kroeger | 1 | 4 |
| Peter A Bisgaard | 1 | 3 |
| Kristopher A Hanson | 1 | 1 |
| Timothy A Garnett | 1 | 1 |
| George A Pavlov | 1 | 1 |
| Erin A Foff | 1 | 1 |
| Jim A Trenkle | 1 | 1 |
| James A Lillie | 1 | 1 |
| Maria A Walker | 1 | 1 |
| Jonathan A Gillis | 1 | 1 |
| Vishwas A Setia | 1 | 1 |
| Nanna A Luneborg | 1 | 1 |
| Robert A Malenka | 1 | 1 |
| Charmaine A Lykins | 1 | 1 |
| Jim A Lillie | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.